ProShare Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,660
Closed -$10.3K 1979
2026
Q1
$10.3K Sell
14,660
-3,869
-21% -$3.61K ﹤0.01% 1856
2025
Q4
$28.7K Sell
18,529
-2,561
-12% -$4.09K ﹤0.01% 2004
2025
Q3
$33.3K Sell
21,090
-3,616
-15% -$6.29K ﹤0.01% 1962
2025
Q2
$53.9K Sell
24,706
-2,961
-11% -$7.17K ﹤0.01% 1982
2025
Q1
$75.5K Sell
27,667
-6,795
-20% -$26.8K ﹤0.01% 1887
2024
Q4
$143K Buy
34,462
+8,481
+33% +$32.1K ﹤0.01% 1982
2024
Q3
$101K Buy
25,981
+7,828
+43% +$33K ﹤0.01% 1880
2024
Q2
$71.2K Sell
18,153
-4,809
-21% -$20.7K ﹤0.01% 1705
2024
Q1
$96.2K Buy
22,962
+1,878
+9% +$8.82K ﹤0.01% 1825
2023
Q4
$99.1K Buy
21,084
+2,964
+16% +$11.5K ﹤0.01% 1782
2023
Q3
$56.5K Buy
18,120
+87
+0.5% +$350 ﹤0.01% 1704
2023
Q2
$82.8K Buy
18,033
+585
+3% +$2.69K ﹤0.01% 1724
2023
Q1
$86.4K Sell
17,448
-2,187
-11% -$10.8K ﹤0.01% 1616
2022
Q4
$107K Buy
19,635
+1,485
+8% +$9.11K ﹤0.01% 1640
2022
Q3
$118K Buy
18,150
+467
+3% +$2.6K ﹤0.01% 1528
2022
Q2
$83K Sell
17,683
-11,455
-39% -$56.4K ﹤0.01% 1639
2022
Q1
$204K Buy
+29,138
New +$199K ﹤0.01% 1875

Other funds holding MXCT

ProShare Advisors's MXCT Position: Q2 2026 in Review

ProShare Advisors sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 14,660 shares — an estimated $10.3K sold.

ProShare Advisors first reported a position in MXCT in Q1 2022 and held it in 17 quarters. The position peaked at $204K in Q1 2022. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • ProShare Advisors reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 14,660 MaxCyte shares in Q2 2026, an estimated $10.3K.
  • ProShare Advisors first reported a position in MaxCyte in Q1 2022 and held it in 17 quarters.
  • ProShare Advisors's MaxCyte position peaked at $204K in Q1 2022.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.